The strutural dynamics of EGFR Exon 19 mutants
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Tyrosine kinase inhibtors are used to treat non-small cell lung cancers (NSCLC) driven by epidermal growth factor receptor (EGFR) mutations in the tyrosine kinase domain (TKD). We characterized the dynamics of purified EGFR exon 19 kinase domain mutants by HDX-MS with or withour erlotinib, one of the first-generation TKIs.
创建时间：
2023-03-11
